Showing 61 - 80 of 364 results
Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub
ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.
A collaboration of scientists from RMIT, ANSTO and the CSIRO has published pioneering research that brings new insights into intrinsically disordered proteins and protein regions (IDPs)/ (IDRs) and how they behave under various physiological processes.
A large team of ANSTO scientists in collaboration with University of Wollongong researchers has developed a new hybrid technique that enhances the effectiveness of a cutting-edge form of radiation therapy for advanced cancer.
Research explores how structure contributes to function in food
Explore ANSTO's range of publications and reports available for the public.
ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.
Environmental scientist with a passion for fieldwork and a lifelong commitment to scientific excellence
Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
Using the past to illuminate the future: Brothers collaborate on important science documentary for ABC TV
An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.
ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial
The Australian led regional cancer care project in medical physics held its first regional training course in Malaysia to progress Rays of Hope.